Binge Eating Disorder Treatment Study

Not Applicable

Completed

• Conditions: Binge Eating Disorder

• Registration Number: NCT00848367
• Lead Sponsor: Ottawa Hospital Research Institute

Brief Summary

The main objective of the proposed study is to determine whether the effectiveness of a group therapy treatment for Binge Eating Disorder (BED) is improved and attrition reduced by optimally matching women with BED who have high attachment anxiety to Group Psychodynamic Interpersonal Psychotherapy (GPIP). This study represents the next phase in a program of research stemming from a previously conducted randomized controlled trial (RCT).

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04
• Study First Submitted: 2009-02-19
• Study First Submitted QC: 2009-02-19
• Study First Posted: 2009-02-20
• Primary Completion: 2010-09
• Study Completion: 2011-12
• Results First Submitted: 2013-06-04
• Results First Submitted QC: 2013-10-17
• Results First Posted: 2013-12-11
• Status Verified: 2014-01
• Last Update Submitted: 2014-01-10
• Last Update Posted: 2014-02-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 102

Inclusion Criteria

•Overweight Women 18 years of age or older who binge eat at least twice per week for the past month.

Exclusion Criteria

• unable speak English
• history of an eating disorder other than Binge Eating Disorder
• concurrent Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of bipolar disorder, psychosis, drug or alcohol problem
• pregnant or planning on becoming pregnant within the next year
• are currently or plan to become enrolled in a weight loss program within the next year

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Frequency of Binge Eating in the Past 28 Days	Pre and Post treatment, 6 months and 1 year

Secondary Outcome Measures

Name	Time	Method
Depression Symptoms	Pre and Post treatment, 6 months and 1 year	Early response to treatment is indicated by a reduction in depression symptoms measured by The Beck Depression Inventory II (BDI-II; Beck, Steer, \& Brown, 1996). The BDI-II is scored by summing the ratings for the 21 items. Each item is rated on a 4-point scale ranging from 0 to 3. The range for this scale is 0-63. Higher scores represent more depressive symptoms. We included cases that were missing up to 8 missing items and calculated scores for participants with missing items by taking the weighted mean and multiplying by 21.

Trial Locations

Locations (1)

Regional Centre for the Treatment of Eating Disorders; 🇨🇦 Ottawa, Ontario, Canada